Jason Pontin Overview
- Firm
- DCVC
- Primary Position
-
General Partner...
- Primary Industry
-
B2B
- Active Board Seats
-
8
- Med. Deal Size
-
000.0
- Med. Valuation
-
000.0
Jason Pontin General Information
Biography
Mr. Jason Pontin serves as a General Partner & Member of the Investment Team at DCVC. He serves as a Board Member at Kanvas Biosciences. He also serves as a Board Member at TaTiO. He also serves as a Board Member at ZwitterCo, Relation Therapeutics, and Aquafortus. He serves as Executive Chairman at Stratos. He is a Co-Founder and serves as a Board Member at Totus Medicines. He has served as Senior Advisor at Flagship Pioneering. He served as a Senior Advisor at Cue Ball. In this role, he leads strategic communications for both Flagship Pioneering and the enterprise's ecosystem of pioneering ventures. He works on originating and developing new companies and is a key strategist for expanding the firm's domains of innovation. As the framer of Flagship's narrative and an architect of the value creation plan for each VentureLabs company, he is also the point of connection between Flagship's ecosystem and governments, NGOs, academia, foundations, and industry. From 2004 to 2017, he was CEO, editor-in-chief, and publisher of MIT Technology Review, the oldest technology publication in the world. He has written for The New York Times, The Economist, and The Financial Times, and still writes regularly for Wired. Before joining MIT Technology Review, he was the editor of Red Herring, a business magazine that was popular during the dot.com boom. At MIT, he was the founder and curator of Solve, MIT's open innovation platform, and the chairman of the MIT Enterprise Forum, the Institute's global community of entrepreneurs; and he reorganized MIT's news and communications as a senior advisor to President Susan Hockfield. In 2013, he delivered a TED talk entitled "Can technology solve our big problems?" which has been viewed more than 1.5 million times. He was educated in the United Kingdom at Harrow School and Keble College, Oxford University. He also serves as an Advisory Board Member at Social Impact Capital.
Contact Information
Address
- 270 University Avenue
- Palo Alto, CA 94301
- United States
Jason Pontin Positions (3)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
DCVC | Investor | General Partner & Member of Investment Team | Palo Alto, CA | Venture Capital | 0000-00-00 |
Strateos | Company | Executive Chairman | Menlo Park, CA | Laboratory Services (Healthcare) | |
Totus Medicines | Company | Co-Founder & Board Member | Emeryville, CA | Drug Discovery | 0000-00-00 |
Jason Pontin Board Seats (8)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Aquafortus | Other Commercial Products | Privately Held (backing) | Venture Capital-Backed | Auckland, New Zealand | 0000-00-0 |
Evonetix | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Cambridge, United Kingdom | 0000-00-0 |
Kanvas | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Monmouth Junction, NJ | 0000-00-0 |
Relation | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | London, United Kingdom | 0000-00-0 |
Strateos | Laboratory Services (Healthcare) | Privately Held (backing) | Venture Capital-Backed | Menlo Park, CA |
Jason Pontin Lead Partner on Deals (8)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
ZwitterCo | 09-Jul-2024 | Later Stage VC (Series B) | 000.00 | Completed | Other Commercial Products | Woburn, MA |
Kanvas | 01-Jul-2024 | 00000 00000 00 | 000.00 | Completed | Drug Discovery | Monmouth Junction, NJ |
Relation | 19-Jan-2024 | 0000 00000 | 000.00 | Completed | Drug Discovery | London, United Kingdom |
Kanvas | 22-Jun-2023 | 0000 00000 | 0000 | Completed | Drug Discovery | Monmouth Junction, NJ |
Aquafortus | 23-Feb-2023 | 00000 00000 00 | 0000 | Completed | Other Commercial Products | Auckland, New Zealand |
ZwitterCo | 03-May-2022 | 00000 00000 00 | 000.00 | Completed | Other Commercial Products | Woburn, MA |
ZwitterCo | 01-Apr-2022 | Secondary Transaction - Private | Completed | Other Commercial Products | Woburn, MA | |
Strateos | 08-Jun-2021 | Later Stage VC (Series B) | 0000 | Completed | Laboratory Services (Healthcare) | Menlo Park, CA |
Jason Pontin Network (102)
Board Members (60)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Stephen Remondi | ZwitterCo | R-Cubed Capital Partners | Woburn, MA | 0000-00-00 |
Colin McCracken | Evonetix | Self | Cambridge, United Kingdom | |
000000 0000 | Relation | Hitachi Ventures | London, United Kingdom | 0000-00-00 |
0000 000000 | Relation | Relation | London, United Kingdom | 0000-00-00 |
00000 00000 | Aquafortus | Self | Auckland, New Zealand |
Portfolio Executives (32)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Ayse Asatekin Ph.D | ZwitterCo | Senior Scientific Advisor | 09-Jul-2024 | Woburn, MA |
Kenneth Morse | ZwitterCo | Advisor | 09-Jul-2024 | Woburn, MA |
000000000 | ZwitterCo | Chief Financial Officer | 09-Jul-2024 | Woburn, MA |
0000000 0 | ZwitterCo | Executive | 09-Jul-2024 | Woburn, MA |
0000 0000 | ZwitterCo | Executive | 09-Jul-2024 | Woburn, MA |
Fund Team Members (10)
Name | Investor | Fund | Fund Location |
---|---|---|---|
Earl Jones | DCVC | DCVC VI | Palo Alto, CA |
Rachel Slaybaugh Ph.D | DCVC | DCVC Opportunity Fund II | Palo Alto, CA |
000000 00000 | DCVC | 0000 0 | Palo Alto, CA |
0000 00000 | DCVC | 0000 0000000 | Palo Alto, CA |
00000 000000 | DCVC | 0000 0000000 | Palo Alto, CA |
Jason Pontin Affiliated Funds (3)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
DCVC Opportunity Fund II | DCVC | Venture Capital - Later Stage | Closed | 2017 | 00000 | 000000 | 000000 | |
DCVC V | DCVC | Venture - General | Closed | 2019 | 00000 | 000000 | 00.00 | 000000 |
DCVC VI | DCVC | Venture - General | Open | 2022 | 00000 | 000000 | -0.00 | 000000 |
Jason Pontin FAQs
-
Who is Jason Pontin?
Mr. Jason Pontin serves as a General Partner & Member of the Investment Team at DCVC.
-
How much does Jason Pontin typically invest?
Jason Pontin's median deal size is 000000.
-
What is Jason Pontin’s main position?
Jason Pontin’s primary position is General Partner & Member of Investment Team.
-
What are the contact details for Jason Pontin?
Jason Pontin’s email address is jaLoremipsu@mdolor and his phone number is +1 (415) 000-0000.
-
How many active board seats does Jason Pontin hold?
Jason Pontin holds 8 board seats including Aquafortus, Evonetix, Kanvas, Relation, and Strateos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »